To include your compound in the COVID-19 Resource Center, submit it here.

Strand’s smart mRNA

How Strand is controlling therapeutic mRNA expression with small molecules

Strand Therapeutics Inc. has developed a method to apply pharmacological control to therapeutic mRNA, enabling the company to regulate when, where and how potently mRNA transcripts are expressed using small molecules. Its initial focus is on delivery of therapeutic mRNA to promote immune responses in cancer.

While strategies for controlling gene therapies, cell

Read the full 522 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers